25682-010-12 |
25682-010 |
HUMAN PRESCRIPTION DRUG |
STRENSIQ |
ASFOTASE ALFA |
SOLUTION |
SUBCUTANEOUS |
20151023 |
N/A |
BLA |
BLA125513 |
Alexion Pharmaceuticals, Inc. |
ASFOTASE ALFA |
18 mg/.45mL |
12 VIAL in 1 CARTON (25682-010-12) / .45 mL in 1 VIAL (25682-010-01) |
25682-013-12 |
25682-013 |
HUMAN PRESCRIPTION DRUG |
STRENSIQ |
ASFOTASE ALFA |
SOLUTION |
SUBCUTANEOUS |
20151023 |
N/A |
BLA |
BLA125513 |
Alexion Pharmaceuticals, Inc. |
ASFOTASE ALFA |
28 mg/.7mL |
12 VIAL in 1 CARTON (25682-013-12) / .7 mL in 1 VIAL (25682-013-01) |
25682-016-12 |
25682-016 |
HUMAN PRESCRIPTION DRUG |
STRENSIQ |
ASFOTASE ALFA |
SOLUTION |
SUBCUTANEOUS |
20151023 |
N/A |
BLA |
BLA125513 |
Alexion Pharmaceuticals, Inc. |
ASFOTASE ALFA |
40 mg/mL |
12 VIAL in 1 CARTON (25682-016-12) / 1 mL in 1 VIAL (25682-016-01) |
25682-019-12 |
25682-019 |
HUMAN PRESCRIPTION DRUG |
STRENSIQ |
ASFOTASE ALFA |
SOLUTION |
SUBCUTANEOUS |
20151023 |
N/A |
BLA |
BLA125513 |
Alexion Pharmaceuticals, Inc. |
ASFOTASE ALFA |
80 mg/.8mL |
12 VIAL in 1 CARTON (25682-019-12) / .8 mL in 1 VIAL (25682-019-01) |